FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2621134536> ?p ?o ?g. }

• W2621134536 endingPage "674" @default.
• W2621134536 startingPage "666" @default.
• W2621134536 abstract "There is an urgent need for biomarkers for the early detection of ovarian cancer (OC). The purpose of this study was to assess whether changes in serum levels of lecithin-cholesterol acyltransferase (LCAT), sex hormone-binding globulin (SHBG), glucose-regulated protein, 78 kDa (GRP78), calprotectin and insulin-like growth factor-binding protein 2 (IGFBP2) are observed before clinical presentation and to assess the performance of these markers alone and in combination with CA125 for early detection. This nested case–control study used samples from the United Kingdom Collaborative Trial of Ovarian Cancer Screening trial. The sample set consisted of 482 serum samples from 49 OC subjects and 31 controls, with serial samples spanning up to 7 years pre-diagnosis. The set was divided into the following: (I) a discovery set, which included all women with only two samples from each woman, the first at<14 months and the second at >32 months to diagnosis; and (ii) a corroboration set, which included all the serial samples from the same women spanning the 7-year period. Lecithin-cholesterol acyltransferase, SHBG, GRP78, calprotectin and IGFBP2 were measured using ELISA. The performance of the markers to detect cancers pre-diagnosis was assessed. A combined threshold model IGFBP2 >78.5 ng ml−1 : LCAT <8.831 μg ml−1 : CA125 >35 U ml−1 outperformed CA125 alone for the earlier detection of OC. The threshold model was able to identify the most aggressive Type II cancers. In addition, it increased the lead time by 5–6 months and identified 26% of Type I subjects and 13% of Type II subjects that were not identified by CA125 alone. Combined biomarker panels (IGFBP2, LCAT and CA125) outperformed CA125 up to 3 years pre-diagnosis, identifying cancers missed by CA125, providing increased diagnostic lead times for Type I and Type II OC. The model identified more aggressive Type II cancers, with women crossing the threshold dying earlier, indicating that these markers can improve on the sensitivity of CA125 alone for the early detection of OC." @default.
• W2621134536 created "2017-06-09" @default.
• W2621134536 creator A5000157899 @default.
• W2621134536 creator A5003204341 @default.
• W2621134536 creator A5005963855 @default.
• W2621134536 creator A5007042275 @default.
• W2621134536 creator A5011742677 @default.
• W2621134536 creator A5019070324 @default.
• W2621134536 creator A5050488701 @default.
• W2621134536 creator A5050644971 @default.
• W2621134536 creator A5050794198 @default.
• W2621134536 creator A5076360005 @default.
• W2621134536 creator A5081082018 @default.
• W2621134536 date "2017-06-29" @default.
• W2621134536 modified "2023-10-16" @default.
• W2621134536 title "A combined biomarker panel shows improved sensitivity for the early detection of ovarian cancer allowing the identification of the most aggressive type II tumours" @default.
• W2621134536 cites W1951029407 @default.
• W2621134536 cites W1961928411 @default.
• W2621134536 cites W1965455082 @default.
• W2621134536 cites W1975581154 @default.
• W2621134536 cites W1980181125 @default.
• W2621134536 cites W1997500225 @default.
• W2621134536 cites W2070369494 @default.
• W2621134536 cites W2098734171 @default.
• W2621134536 cites W2099745794 @default.
• W2621134536 cites W2100339207 @default.
• W2621134536 cites W2108787610 @default.
• W2621134536 cites W2109058145 @default.
• W2621134536 cites W2115258708 @default.
• W2621134536 cites W2130202432 @default.
• W2621134536 cites W2131483928 @default.
• W2621134536 cites W2138304815 @default.
• W2621134536 cites W2149882132 @default.
• W2621134536 cites W2155587446 @default.
• W2621134536 cites W2163459778 @default.
• W2621134536 cites W2164890175 @default.
• W2621134536 cites W2165948908 @default.
• W2621134536 cites W2182047966 @default.
• W2621134536 cites W2271969753 @default.
• W2621134536 cites W2274620331 @default.
• W2621134536 cites W2343801220 @default.
• W2621134536 doi "https://doi.org/10.1038/bjc.2017.199" @default.
• W2621134536 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5572165" @default.
• W2621134536 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28664912" @default.
• W2621134536 hasPublicationYear "2017" @default.
• W2621134536 type Work @default.
• W2621134536 sameAs 2621134536 @default.
• W2621134536 citedByCount "42" @default.
• W2621134536 countsByYear W26211345362017 @default.
• W2621134536 countsByYear W26211345362018 @default.
• W2621134536 countsByYear W26211345362019 @default.
• W2621134536 countsByYear W26211345362020 @default.
• W2621134536 countsByYear W26211345362021 @default.
• W2621134536 countsByYear W26211345362022 @default.
• W2621134536 countsByYear W26211345362023 @default.
• W2621134536 crossrefType "journal-article" @default.
• W2621134536 hasAuthorship W2621134536A5000157899 @default.
• W2621134536 hasAuthorship W2621134536A5003204341 @default.
• W2621134536 hasAuthorship W2621134536A5005963855 @default.
• W2621134536 hasAuthorship W2621134536A5007042275 @default.
• W2621134536 hasAuthorship W2621134536A5011742677 @default.
• W2621134536 hasAuthorship W2621134536A5019070324 @default.
• W2621134536 hasAuthorship W2621134536A5050488701 @default.
• W2621134536 hasAuthorship W2621134536A5050644971 @default.
• W2621134536 hasAuthorship W2621134536A5050794198 @default.
• W2621134536 hasAuthorship W2621134536A5076360005 @default.
• W2621134536 hasAuthorship W2621134536A5081082018 @default.
• W2621134536 hasBestOaLocation W26211345361 @default.
• W2621134536 hasConcept C121608353 @default.
• W2621134536 hasConcept C126322002 @default.
• W2621134536 hasConcept C134018914 @default.
• W2621134536 hasConcept C2777911890 @default.
• W2621134536 hasConcept C2780427987 @default.
• W2621134536 hasConcept C2781197716 @default.
• W2621134536 hasConcept C30092816 @default.
• W2621134536 hasConcept C55493867 @default.
• W2621134536 hasConcept C71315377 @default.
• W2621134536 hasConcept C71924100 @default.
• W2621134536 hasConcept C86803240 @default.
• W2621134536 hasConcept C90924648 @default.
• W2621134536 hasConceptScore W2621134536C121608353 @default.
• W2621134536 hasConceptScore W2621134536C126322002 @default.
• W2621134536 hasConceptScore W2621134536C134018914 @default.
• W2621134536 hasConceptScore W2621134536C2777911890 @default.
• W2621134536 hasConceptScore W2621134536C2780427987 @default.
• W2621134536 hasConceptScore W2621134536C2781197716 @default.
• W2621134536 hasConceptScore W2621134536C30092816 @default.
• W2621134536 hasConceptScore W2621134536C55493867 @default.
• W2621134536 hasConceptScore W2621134536C71315377 @default.
• W2621134536 hasConceptScore W2621134536C71924100 @default.
• W2621134536 hasConceptScore W2621134536C86803240 @default.
• W2621134536 hasConceptScore W2621134536C90924648 @default.
• W2621134536 hasIssue "5" @default.
• W2621134536 hasLocation W26211345361 @default.
• W2621134536 hasLocation W26211345362 @default.
• W2621134536 hasLocation W26211345363 @default.
• W2621134536 hasLocation W26211345364 @default.
• W2621134536 hasLocation W26211345365 @default.

• next